2 -11 (73) 2024 - Ubaidova D.S., Ismatova M.N. - MODERN PRINCIPLES OF TREATING ULCERATIVE COLITIS: FROM SIMPLE TO COMPLEX

MODERN PRINCIPLES OF TREATING ULCERATIVE COLITIS: FROM SIMPLE TO COMPLEX

Ubaidova D.S. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Ismatova M.N. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Currently, the choice of medications for the treatment of non-specific ulcerative colitis and the determination of its duration remain a controversial issue. When treating ulcerative colitis, 5-aminosalicylic acid derivatives (mesalazine) are used as a first-line therapy. The choice of a drug and its form requires an individual approach, and when making a decision about therapy, it is necessary to take into account the duration of the inflammatory process, the activity of the inflammatory process, and the level of drug safety.

Key words: Nonspecific ulcerative colitis, 5-aminosalicylic acid preparations, mesalazine

First page

10

Last page

12

For citation:Ubaidova D.S., Ismatova M.N. - MODERN PRINCIPLES OF TREATING ULCERATIVE COLITIS: FROM SIMPLE TO COMPLEX//New Day in Medicine 11(73)2024 10-12 https://https://newdayworldmedicine.com/en/new_day_medicine/11-73-2024

List of References

  1. Cosnes J., Gower-Rousseau C., Seksik P., Cortot A. Epidemiology and natural history of infl ammatory bowel diseases. Gastroenterology. 2011;140:1785-94.
  2. Silverberg M.S. et al. Toward an integrated clinical, molecular and serological classifi cation of infl ammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 2005;19(Suppl A):5-36.
  3. Григорьев П.Я. Справочное руководство по гастроэнтерологии / П. Я. Григорьев, Э. П. Яковенко. – М.: Мед. информ. агентство, 1997; 480 с. Grigor’ev P. Ya., Yakovenko E. P. Spravochnoe rukovodstvo po gastroehnterologii [Th e reference guide on gastroenterology]. Moscow, Med. inform. agentstvo Publ., 1997; 480 p. (In Russ.)
  4. Baumgart DC. Th e Diagnosis and Treatment of Crohn’s Disease and Ulcerative Colitis. Deutsches Ärzteblatt International Dtsch Arztebl Int. 2009;106(8):123-33.
  5. D’Haens G. et al. A review of activity indices and effi cacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007;132:763-86.
  6. Григорьева Г.А., Мешалкина Н. Ю. О проблеме системных проявлений воспалительных заболеваний кишечника. Фарматека. 2011;15:44-49.
  7. Масевич Ц.Г. Современная фармакотерапия хро ни ческих воспалительных заболеваний кишечника / Ц.Г. Масевич, С.И. Ситкин // Aqua Vitae. 2001;1:37-41.
  8. Справочник по колопроктологии под редакцией проф. Шелыгина Ю. А., проф. Благодарного Л. А. «Литтерра». 2012; C.460-522.
  9. Убайдова Д.С Неспецифический язвенний колит:современные подходы к диагностике и лечению SYNERGY: Journl of Ethics and Governance 2023 Dec;3(12) ISSN: 2181-2616
  10. Ubaydova D.S. Molecular genetic diagnosis of inflammatory bowel diseases Asian journal of Pharmaceutical and biological research 2023 JAN.-APR;12(1).
  11. Ubaydova D. S. Nonspecific Ulcerative Colitis: Modern Approaches to Diagnosis and Treatment //Research journal of trauma and disability studies 2023 Dec;2(12).

    file

    download